Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia

MJ Hursting, BE Lewis… - Clinical and applied …, 2005 - journals.sagepub.com
Argatroban, a direct thrombin inhibitor used for thromboprophylaxis or treatment in heparin-
induced thrombocytopenia (HIT), is routinely monitored using the activated partial …

Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia.

MJ Hursting, BE Lewis… - Clinical and Applied …, 2005 - europepmc.org
Argatroban, a direct thrombin inhibitor used for thromboprophylaxis or treatment in heparin-
induced thrombocytopenia (HIT), is routinely monitored using the activated partial …

Transitioning from Argatroban to Warfarin Therapy in Patients with Heparin-induced Thrombocytopenia

MJ Hursting, BE Lewis, DE Macfarlane - Clinical and Applied …, 2005 - cir.nii.ac.jp
抄録< jats: p> Argatroban, a direct thrombin inhibitor used for thromboprophylaxis or
treatment in heparin-induced thrombocytopenia (HIT), is routinely monitored using the …

[PDF][PDF] Transitioning from Argatroban to Warfarin Therapy in Patients with Heparin-induced Thrombocytopenia

MJ Hursting, BE Lewis, DE Macfarlane - 2005 - scholar.archive.org
Argatroban, a direct thrombin inhibitor used for thromboprophylaxis or treatment in heparin-
induced thrombocytopenia (HIT), is routinely monitored using the activated partial …

Transitioning from Argatroban to Warfarin Therapy in Patients with Heparin-induced Thrombocytopenia.

MJ Hursting, BE Lewis… - Clinical & Applied …, 2005 - search.ebscohost.com
Argatroban, a direct thrombin inhibitor used for thromboprophylaxis or treatment in heparin-
induced thrombocytopenia (HIT), is routinely monitored using the activated partial …

[PDF][PDF] Transitioning from Argatroban to Warfarin Therapy in Patients with Heparin-induced Thrombocytopenia

MJ Hursting, BE Lewis, DE Macfarlane - 2005 - Citeseer
Argatroban, a direct thrombin inhibitor used for thromboprophylaxis or treatment in heparin-
induced thrombocytopenia (HIT), is routinely monitored using the activated partial …

Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia

MJ Hursting, BE Lewis… - Clinical and applied …, 2005 - pubmed.ncbi.nlm.nih.gov
Argatroban, a direct thrombin inhibitor used for thromboprophylaxis or treatment in heparin-
induced thrombocytopenia (HIT), is routinely monitored using the activated partial …

Transitioning from Argatroban to Warfarin Therapy in Patients with Heparin-induced Thrombocytopenia

MJ Hursting, BE Lewis, DE Macfarlane - Clinical and applied …, 2005 - iro.uiowa.edu
Argatroban, a direct thrombin inhibitor used for thromboprophylaxis or treatment in heparin-
induced thrombocytopenia (HIT), is routinely monitored using the activated partial …

[引用][C] Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia

H MJ - Clin Appl Thromb Hemost, 2005 - cir.nii.ac.jp
Transitioning from argatroban to warfarin therapy in patients with heparin-induced
thrombocytopenia | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Transitioning from Argatroban to Warfarin Therapy in Patients with Heparin-induced Thrombocytopenia.

MJ Hursting, BE Lewis… - Clinical & Applied …, 2005 - search.ebscohost.com
Argatroban, a direct thrombin inhibitor used for thromboprophylaxis or treatment in heparin-
induced thrombocytopenia (HIT), is routinely monitored using the activated partial …